Basic Information
| LncRNA/CircRNA Name | MNX1-AS1 |
| Synonyms | NA |
| Region | GRCh38_7:157010805-157016426 |
| Ensemble | ENSG00000243479 |
| Refseq | NR_038835 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | qPCR, Western blot |
| Sample | prostate cancer tissues and cell lines (LNCaP, DU145, PC3 and C4-2)prostate epithelial cell line (RWPE) |
| Expression Pattern | up-regulated |
| Function Description | MNX1-AS1 is up-regulated in prostate cancer tissues and cell lines |
| Pubmed ID | 30980513 |
| Year | 2019 |
| Title | Knockdown of lncRNA MNX1-AS1 suppresses cell proliferation, migration, and invasion in prostate cancer. |
External Links
| Links for MNX1-AS1 | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |